Sutro Biopharma STRO
NASDAQ STRO
$15.97 -0.14 (-0.87%)
At close: Oct 1, 2026 · 4:00 PM EDT

Sutro Biopharma (STRO) Price to FCF (2018 - 2019)

Updated

Sutro Biopharma's (STRO) Price to FCF came in at 65.72 for Q2 2019, up 53.0% from the prior quarter.

Analysis

Sutro Biopharma (STRO) Price to FCF (2018 - 2019) Analysis & Trends

For FY2018, Sutro Biopharma's Price to FCF stood at 4.67.

  • According to Business Quant data, Price to FCF for the three prior quarters was 42.95 (Q1 2019), 4.67 (Q4 2018) and 0.58 (Q3 2018).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 Sutro Biopharma 267.04 Mn -411.46 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2019 65.72
Mar 31, 2019 42.95
Dec 31, 2018 4.67
Sep 30, 2018 0.58
API Access

Sutro Biopharma Price to FCF API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=price-to-fcf&ticker=STRO&period=max&api_key=YOUR_API_KEY